Trevena
1 known investors
Trevena is a biopharmaceutical company developing medicines for central nervous system (CNS) disorders, with a pipeline based on Nobel Prize-winning research. Its portfolio includes the FDA-approved acute pain injection OLINVYK and investigational candidates for conditions such as diabetic neuropathic pain, epilepsy, acute migraine, and opioid use disorder.
Investors · 1
Frequently asked questions
- What does Trevena do?
- Trevena is a biopharmaceutical company developing medicines for central nervous system (CNS) disorders, with a pipeline based on Nobel Prize-winning research. Its portfolio includes the FDA-approved acute pain injection OLINVYK and investigational candidates for conditions such as diabetic neuropathic pain, epilepsy, acute migraine, and opioid use disorder.
- Who are Trevena's investors?
- Trevena's investors include New Enterprise Associates (NEA).